Concentrix (CNXC) | Financial Analysis & Statements
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
9.6B
Gross Profit
3.4B
35.86%
Operating Income
596.4M
6.20%
Net Income
251.2M
2.61%
EPS (Diluted)
$3.71
Balance Sheet Metrics
Total Assets
12.0B
Total Liabilities
8.0B
Shareholders Equity
4.0B
Debt to Equity
1.97
Cash Flow Metrics
Operating Cash Flow
648.8M
Free Cash Flow
428.7M
Revenue & Profitability Trend
Concentrix Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 9.6B | 7.1B | 6.3B | 5.6B | 4.7B |
| Cost of Goods Sold | 6.2B | 4.5B | 4.1B | 3.6B | 3.1B |
| Gross Profit | 3.4B | 2.6B | 2.3B | 2.0B | 1.7B |
| Operating Expenses | 2.9B | 1.9B | 1.6B | 1.4B | 1.4B |
| Operating Income | 596.4M | 661.3M | 640.2M | 572.4M | 308.8M |
| Pre-tax Income | 299.3M | 408.2M | 605.0M | 555.7M | 267.9M |
| Income Tax | 48.1M | 94.4M | 169.4M | 150.1M | 103.1M |
| Net Income | 251.2M | 313.8M | 435.6M | 405.6M | 164.8M |
| EPS (Diluted) | $3.71 | $5.70 | $8.28 | $7.70 | $3.19 |
Income Statement Trend
Concentrix Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 2.8B | 2.9B | 1.8B | 1.5B | 1.4B |
| Non-Current Assets | 9.1B | 9.6B | 4.9B | 3.5B | 3.8B |
| Total Assets | 12.0B | 12.5B | 6.7B | 5.0B | 5.2B |
| Liabilities | |||||
| Current Liabilities | 2.0B | 2.1B | 1.1B | 968.2M | 1.0B |
| Non-Current Liabilities | 6.0B | 6.3B | 2.8B | 1.5B | 1.9B |
| Total Liabilities | 8.0B | 8.3B | 4.0B | 2.4B | 2.9B |
| Equity | |||||
| Total Shareholders Equity | 4.0B | 4.1B | 2.7B | 2.6B | 2.3B |
Balance Sheet Composition
Concentrix Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 251.2M | 313.8M | 435.6M | 405.6M | 164.8M |
| Operating Cash Flow | 648.8M | 654.0M | 600.4M | 551.8M | 489.6M |
| Investing Activities | |||||
| Capital Expenditures | -238.8M | -180.5M | -140.0M | -149.1M | -171.3M |
| Investing Cash Flow | -244.3M | -2.1B | -1.8B | -78.6M | -109.2M |
| Financing Activities | |||||
| Dividends Paid | -83.8M | -63.5M | -53.4M | -13.1M | 0 |
| Financing Cash Flow | -497.6M | 1.8B | 1.2B | -415.6M | -1.8B |
| Free Cash Flow | 428.7M | 497.5M | 460.7M | 365.1M | 336.3M |
Cash Flow Trend
Concentrix Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
12.97
Forward P/E
4.21
Price to Book
0.82
Price to Sales
0.34
PEG Ratio
4.21
Profitability Ratios
Profit Margin
2.81%
Operating Margin
7.94%
Return on Equity
6.62%
Return on Assets
3.92%
Financial Health
Current Ratio
1.65
Debt to Equity
142.31
Beta
0.61
Per Share Data
EPS (TTM)
$3.99
Book Value per Share
$63.21
Revenue per Share
$148.50
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| cnxc | 3.3B | 12.97 | 0.82 | 6.62% | 2.81% | 142.31 |
| International | 268.8B | 49.52 | 10.00 | 21.85% | 8.71% | 247.98 |
| Accenture plc | 177.8B | 22.72 | 5.82 | 26.93% | 11.61% | 25.88 |
| Epam Systems | 9.5B | 23.53 | 2.61 | 11.57% | 8.47% | 4.34 |
| Caci International | 10.0B | 21.42 | 2.69 | 13.48% | 5.70% | 94.06 |
| Kyndryl Holdings | 8.9B | 36.68 | 7.29 | 20.54% | 1.67% | 297.00 |
Financial data is updated regularly. All figures are in the company's reporting currency.